Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) EBITDA (2025 - 2026)

Updated

Global Innovative Platforms (GIPL) recorded EBITDA of -$229,759 in fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$211,818 a year earlier.

Analysis

Global Innovative Platforms (GIPL) EBITDA (2025 - 2026) Analysis & Trends

On a TTM basis, Global Innovative Platforms' EBITDA came in at -$624,218 as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 9.10 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 8.33 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 5.09 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 1.30 Bn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - -229,759.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -229,759.00
Mar 31, 2026 -138,225.00
Dec 31, 2025 -44,416.00
Jun 30, 2025 -211,818.00
API Access

Global Innovative Platforms EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=GIPL&period=max&api_key=YOUR_API_KEY